神经基因-1受体对抗性降低了子模型中的非过敏眼红
Lingjia Liu1,2, Shudan Wang1,3, Tomas Blanco1
1Schepens Eye Research Institute of Massachusetts Eye and Ear, Harvard Medical School, Boston, Massachusetts, USA.
概括
局部神经素-1受体 (NK1R) 抗剂L-703,606有效地预防和缓解子的非过敏眼红. 这种NK1R阻断在诱导期间或之后应用时显著减少了红色,证明了治疗潜力.
科学领域:
- 眼科医生 眼科 眼科
- 药理学 药理学是指药理学的学科.
- 免疫学 免疫学 免疫学
背景情况:
- 非过敏的眼睛红是很常见的情况.
- 神经素-1受体 (NK1R) 抗剂已经显示出抗炎性质.
- 通过使用达帕醇化建立了非过敏眼红的子模型.
研究的目的:
- 评估局部NK1R抗剂在非过敏眼红的子模型中的治疗疗效.
- 为了确定NK1R阻断是否可以预防或减轻诱导的眼睛红.
主要方法:
- 在子中使用达帕醇化水滴诱导非过敏的眼睛红色.
- NK1R抗剂L-703,606被局部应用,无论是与达皮帕佐尔诱导同时或在达皮帕佐尔诱导后20分钟.
- 从捕获的图像中使用基于ImageJ的眼睛红色指数 (ORI) 计算来量化眼睛红色.
主要成果:
- 达皮巴醇化物显著增加了ORI得分,表明引起的眼睛红.
- 当局用L-703,606在与达皮帕佐同时使用时,显著抑制了ORI得分的增加,约为40%.
- L-703,606也有效地抑制了大约30%的ORI得分,当在达皮帕佐尔诱导后20分钟应用时.
结论:
- 局部阻断NK1R是预防和缓解非过敏眼红的有效策略.
- NK1R抗剂L-703,606在这种新型动物模型中显示出显著的治疗潜力.
- 这些发现表明,对于非过敏性眼睛红的潜在新治疗方法.
相关概念视频
01:27Open Angle Glaucoma: Treatment
427
In open-angle glaucoma, the iridocorneal angle remains open, but the trabecular meshwork becomes stiff, slowing down the outflow of aqueous humor. This causes a buildup of aqueous humor in the anterior chamber, leading to a sudden increase in intraocular pressure. The treatment for open-angle glaucoma focuses on reducing the elevated intraocular pressure by either decreasing the secretion of aqueous humor or increasing its outflow.
Drugs such as carbonic anhydrase inhibitors, α2- and...
Drugs such as carbonic anhydrase inhibitors, α2- and...
427
01:28Chemotherapy-Induced Nausea and Vomiting: Neurokinin-1 Receptor Antagonists
159
Neurokinin 1 (NK1) receptors are distributed across the GI tract, vagal afferents, and key CNS regions including the central vomiting center and chemoreceptor trigger zone (CTZ) Chemotherapy agents stimulate enterochromaffin cells in the gastrointestinal (GI) tract to release large amounts of substance P (SP). SP is a neuropeptide released by specific sensory nerves in response to many different stressors, including those in the GI mucosa affected by chemotherapy. SP binds and activates...
159